MiR-203/TGF-β/Smad2 expression represents an important tumor suppressor signaling pathway for bone metastasis in NSCLC, as patients with bone metastasis exhibited lower tumor tissue miR-203 expression than those without bone metastasis [161]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.